Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Wortmannin
Cat. No.:
OB0225LY-0415
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Wortmannin is a compound that specifically inhibits PI3K (phosphatidylinositol 3 kinase) and effectively affects cell signaling pathways.
Synonym:
SL-2052; KY-12420; 19545-26-7; (1S,6bR,9aS,11R,11bR)-1-(Methoxymethyl)-9a,11b-dimethyl-3,6,9-trioxo-1,6,6b,7,8,9,9a,10,11,11b-decahydro-3H-furo[4,3,2-de]indeno[4,5-h]isochromen-11-yl acetate; 3H-Furo[4,3,2-de]indeno[4,5-h]-2-benzopyran-3,6,9-trione,11-(acetyloxy)-1,6b,7,8,9a,10,11,11b-octahydro-1-(methoxymethyl)-9a,11b-dimethyl-, (1S,6bR,9aS,11R,11bR)-
CAS No.:
19545-26-7
Compound CID:
312145
Formula:
C23H24O8
Formula Weight:
428.43
Specification
Relative Density:
1.39 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Wortmannin can be used for cell signaling pathway studies or play an important role in cancer research.
Library Information
Targets:
PIKKs; Serine/Threonine kinases
Receptors:
ATM/ATR; DNA-PK; MLCK; PI3K; PLK; PlK1; PlK3
Pathways:
Autophagy; DNA damage/DNA repair; Metabolism; Cell cycle/Checkpoint; Microbiology/Virology; PI3K/Akt/mTOR signaling
Plate Number:
AOCL-6
Plate Location:
c11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
21.4 mg/mL; 50 mM
Ethanol Max Solubility:
2.1 mg/mL; 5 mM
